Defender Pharmaceuticals, Inc
Barry Feinberg is the CEO and President of Defender Pharmaceuticals, Inc and a board member of Frontenac Surgery And Spine Care Center, L.L.C. Barry is also a physician at Injury Specialists, specializing in multi-specialty outpatient pain management. Barry has extensive experience in the medical field, including roles such as Co-Director of Post-Surgical Intensive Care Unit at Deborah Heart and Lung Center and Chairman of the Department of Anesthesia at DePaul Health Center. With a Doctor of Medicine degree from State University of New York Downstate Health Sciences University and a Doctor of Law degree from Washington University in St. Louis School of Law, Barry Feinberg brings a diverse skill set to their various positions.
This person is not in any teams
Defender Pharmaceuticals, Inc
Defender Pharmaceuticals, Inc., located in St. Louis, MO, is a privately held life sciences company focused on discovering, developing and commercializing medicines to help safeguard health across civilian and military populations. Our work with the Department of Defense, NASA, the Department of Veterans Affairs, and other institutions advance our mission to improve the health of patients and help make the world a more secure place. For more information about Defender Pharmaceuticals, Inc. please visit our website at www.defenderpharma.com.